Drug concentration and antidrug antibodies in patients with psoriasis treated with adalimumab or etanercept

Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis

(2015) Stef P. Menting et al.   JAMA Dermatology

Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study

(2013) S.K. Mahil et al.   BRITISH JOURNAL OF DERMATOLOGY

Antidrug antibodies in psoriasis: a systematic review

(2013) L. Hsu et al.   BRITISH JOURNAL OF DERMATOLOGY

Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis

(2013) Stef P. Menting et al.   JAMA Dermatology

Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis

(2012) Hidetoshi Takahashi et al.   JOURNAL OF DERMATOLOGY

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

(2007) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY